Event Type: Earnings Conference Call to discuss unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 FY26-27).
Date and Time: The call was held on Monday, November 16, 2026. The specific time and time zone were not disclosed in the provided data.
Purpose: Discussion of quarterly results, business updates, strategic initiatives, and future outlook.
Earnings Timing: The meeting was held after the earnings announcement, as it discusses already announced Q2 FY27 results.
Management Participants:
Mr. Manish Grover – Managing Director
Mr. Ankush Kaushal – Whole-Time Director
Mr. Nanak Chand – Chief Financial Officer
Moderator: Ms. Soumya Chhajed from Go India Advisors, LLP
Availability of Materials: The transcript of the earnings conference call has been made available on the company's website at: https://jeenasikho.com/wp-content/uploads/2026/11/Jeena-Sikho-Q2FY27-Earning-Call-Transcript.pdf
UPSI Statement: The moderator noted that the discussion may include forward-looking statements that must be viewed in conjunction with business risks, but no explicit statement about unpublished price sensitive information was made.
Financial Highlights Discussed
Q2 FY27 Performance: Revenue from operations was INR235 crores (up 24% YoY, 5% QoQ), Gross margin was 88%, EBITDA was INR72 crores with 31% margin, PAT was INR36 crores.
H1 FY27 Performance: Revenue was INR460 crores (up 26% YoY), EBITDA was INR164 crores with 36% margin, PAT was INR102 crores.
Expense Analysis: Operating expenses rose 83% YoY driven by:
Advertisement and promotion expense increased by INR13.4 crores
Employee benefit expense increased by INR4.1 crores
Other increases in leasehold, courier, and development expenses
Strategic and Business Updates
Network Expansion: Currently 62 hospitals, 60 clinics and daycare centers, approximately 2,424 operational beds across 23 states
Accreditations: 52 hospitals NABH accredited with 12 more in pipeline
New Launches: 10 new products launched in Q2, wellness resort in Himachal Pradesh (108 rooms, 24 villas) launching December 15, 2026
Capacity Pipeline: 460 beds in pipeline, with focus on disciplined expansion
Strategy Shift: Revised OTC strategy, moving away from high-acquisition cost models to focus on converting product customers to higher-margin Panchakarma services
Government Business: Awaiting Ayushman scheme implementation, planning to limit government business to 15% of total revenue
Guidance and Outlook
FY27 Guidance: Reaffirmed growth guidance of 20-25% revenue growth and EBITDA margin target of 35-40%
H2 Priorities: Increase occupancy on new beds, scale new products and pharmacy channels, disciplined capacity expansion, maintain cash flow quality
Long-term Vision: Target of 7,000-10,000 beds in 3-5 years, maintaining 35-40% EBITDA margins at scale
Additional Notes Section
Attachments: The regulatory filing indicates the submission of the earnings call transcript to stock exchanges as required by SEBI LODR regulations.
Financial Data: The announcement itself did not contain financial data, but the referenced transcript contained extensive financial and operational details from the earnings call.
Compliance: The filing was made pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.